Myocardial bridging is associated with alteration in coronary vasoreactivity

Joerg Herrmann1, Stuart T Higano, Ryan J Lenon

  • 1Division of Cardiovascular Diseases, Mayo Clinic Rochester, 200 First Street S.W., Rochester, MN 55905, USA.

European Heart Journal
|December 2, 2004
PubMed

Insights

Myocardial bridging (MB) impairs endothelium-dependent vasoreactivity, causing vasoconstriction. This functional change, along with enhanced wall shear rate (WSR), may worsen the clinical presentation of MB.

Area of Science:

  • Cardiovascular Research
  • Medical Physiology
  • Congenital Heart Disease

Background:

  • Altered shear stress is linked to endothelial dysfunction.
  • Myocardial bridging (MB), a congenital condition, alters shear stress but its effect on vasoreactivity is unknown.

Purpose of the Study:

  • To investigate the impact of myocardial bridging on coronary vasoreactivity and wall shear stress.

Main Methods:

  • A case-control study compared 29 MB patients with 58 controls.
  • Coronary artery vasoreactivity was assessed using acetylcholine and nitroglycerine infusions.
  • Wall shear rate (WSR) and coronary flow velocity reserve (CFVR) were measured.

Main Results:

  • Myocardial bridging sites showed significantly greater vasoconstriction in response to acetylcholine compared to other segments and controls.
  • No differences were observed in nitroglycerine response or CFVR between groups.
  • Baseline and acetylcholine-stimulated WSR were higher at the myocardial bridging site.

Conclusions:

  • Myocardial bridging is associated with increased WSR and impaired endothelium-dependent vasodilation.
  • These functional alterations may exacerbate lumen compression and clinical symptoms in MB.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957